Kaiser Permanente researchers' study identified top search terms in the electronic health record and analyzed the relationships among search terms. They then used these data to identify what users were looking for most – and consider how they might find it more easily.
Patients who followed more medical advice after a heart attack were more likely to survive years later, and their prospects improved with every additional recommendation they followed, according to new research from Kaiser Permanente published in the Journal of the American Heart Association.
David Baer, MD, cofounded the KP Oncology Clinical Trials program in the 1980s. He has enrolled significant numbers of patients in these trials, and helped expand the regional effort into a national KP program. As a leading member of the Northern California Central Research Committee for most of his career, he provides valuable experience in the practicality of research within Kaiser Permanente.
Pregnant women with depression were more likely to eat poor diets with a higher intake of empty calories and lower intake of greens, beans, and fruit, according to an analysis of 1,160 adult pregnant women who were treated at Kaiser Permanente Northern California.
Diabetes, medication safety, and understanding chronic conditions are just some of the research areas a new class of postdoctoral fellows at the Kaiser Permanente Northern California Division of Research will support. The 3 early-career researchers began their appointments this past year.
Kaiser Permanente's Northern California hospitals reduced hospitalizations and readmissions even as patients' conditions increased in severity, a new analysis shows.
Tyson attended the 2016 celebration honoring Kaiser Permanente participants in CARDIA, a landmark national study of cardiovascular health and disparities.
Kaiser Permanente investigator Andrew Karter and colleagues will receive $3.2 million over 5 years from the National Institute on Aging to study what older patients with diabetes want from their treatment.
A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.